1988
DOI: 10.1007/bf02555148
|View full text |Cite
|
Sign up to set email alerts
|

Evidence for a prostaglandin-mediated bone resorptive mechanism in subjects with fasting hypercalciuria

Abstract: This study was performed to assess whether treatment with prostaglandin synthesis inhibitors decreases calcium excretion in patients with idiopathic hypercalciuria. Nineteen hypercalciuric (12 with fasting hypercalciuria (FH), 7 with nonfasting hypercalciuria (NFH) and 8 control non-hypercalciuric stone formers were treated with sodium diclofenac, 50 mg t.i.d. for 2 weeks. After a washout phase, 7 FH patients received 200 mg/day of sulindac (a nonsteroidal antiinflammatory agent (NSAID) inactive on renal prost… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
11
0

Year Published

1989
1989
2008
2008

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(12 citation statements)
references
References 24 publications
1
11
0
Order By: Relevance
“…Moreover, PGE 2 could induce hypercalciuria by stimulating renal 1 ␣ -hydroxylase activity and consequently serum 1,25-(OH) 2 vitamin D concentrations, which play a central role in calcium metabolism at the intestinal, renal, and bone levels. A disorder in vitamin D's pathway is the most attractive hypothesis to explaining the different forms of hypercalciuria [17][18][19]. The possibility that PGE 2 could increase 1,25-(OH) 2 vitamin D synthesis was supported by the fi ndings of our group [13] and those of Hasanoglu et al [20] of a positive correlation between 1,25-(OH) 2 vitamin D and PGE 2 in adults and children with idiopathic hypercalciuria.…”
Section: Best-fit Modelsupporting
confidence: 74%
“…Moreover, PGE 2 could induce hypercalciuria by stimulating renal 1 ␣ -hydroxylase activity and consequently serum 1,25-(OH) 2 vitamin D concentrations, which play a central role in calcium metabolism at the intestinal, renal, and bone levels. A disorder in vitamin D's pathway is the most attractive hypothesis to explaining the different forms of hypercalciuria [17][18][19]. The possibility that PGE 2 could increase 1,25-(OH) 2 vitamin D synthesis was supported by the fi ndings of our group [13] and those of Hasanoglu et al [20] of a positive correlation between 1,25-(OH) 2 vitamin D and PGE 2 in adults and children with idiopathic hypercalciuria.…”
Section: Best-fit Modelsupporting
confidence: 74%
“…The origin of such a decrease has been investigated over the past few years. The pathogenesis of bone mass loss has been related to increased monocyte interleukin-1 activity [3], to increased prostaglandin E2 (PGE2) production [4], to decreased dietary calcium intake [5,6], to an increase in animal protein intake [7] and, recently, to increased interleukin-6 activity [8].…”
Section: Introductionmentioning
confidence: 99%
“…In previous studies investigating the relationship between calcium stone formers and reduced BMD, patients were classified according to the amount of urinary calcium excretion, followed by an analysis of the corresponding BMD [2][3][4][5]17]. The focus of our investigation was different.…”
Section: Discussionmentioning
confidence: 99%